The NeXtStep in SPR based fragment screening

Biosensors & Bioelectronics

ISSN: 2155-6210

Open Access

The NeXtStep in SPR based fragment screening

6th International Conference and Exhibition on Biosensors & Bioelectronics

September 22-23, 2016 Phoenix, USA

Eric L Reese

SensiQ Technologies Inc., USA

Posters & Accepted Abstracts: J Biosens Bioelectron

Abstract :

SensiQâ??s patented gradient injection methods provide KDâ??s from single injections, allowing SensiQ instruments to eliminate secondary screens such as one competitorâ??s â??Affinity Screenâ?. No other SPR providers have gradient injection technology. SensiQ Pioneer FE customers have demonstrated that a combination of excellent sensitivity, OneStep?® gradient injections and the integrated Active Selection software provides superior results over other SPR suppliers. Now SensiQ has developed a new binding competition assay method for rapidly screening fragments, NeXtStep. Like OneStep?®, NeXtStep enables full kinetic analysis in single competition injection and competition is clearly seen as a lack of binding in the presence of the competitor. Taken together, OneStep?® and NeXtStep enable straight forward fragment screening workflow optimization and thus a faster drug discovery process.

Biography :


Google Scholar citation report
Citations: 1751

Biosensors & Bioelectronics received 1751 citations as per Google Scholar report

Biosensors & Bioelectronics peer review process verified at publons

Indexed In

arrow_upward arrow_upward